Franklyn Health, a fast-growing clinical research organisation, was proud to take part in CRACONNECT Live 2026 — the first international conference dedicated entirely to Clinical Research Associates (CRAs). Held at the iconic Pueblo Español in Barcelona, the event brought together hundreds of clinical research professionals from across the global clinical trials industry.

Representing Franklyn Health, Laura Van Vaeck delivered a keynote talk to a large and engaged audience, cementing the company’s growing reputation as a thought leader in clinical research and clinical trial management.

Driving Clinical Trial Success Through Study Start-Up Excellence

Laura’s talk focused on a critical theme in modern clinical research: how close collaboration between CRAs and study start-up teams improves both site selection and speed to first patient in. As she explained, study start-up is where clinical trial timelines are won or lost.

Delays during the start-up phase compound across the entire trial lifecycle, making early cross-functional collaboration one of the most important drivers of clinical trial success. By aligning CRAs and start-up teams from day one, sponsors and clinical research organisations can accelerate site activation, strengthen site selection, and reduce costly downstream delays.

A Growing Force in Clinical Research

Franklyn Health’s presence on the CRACONNECT Live 2026 stage reflects the company’s continued growth and rising profile within the clinical trials sector. Speaking in front of a packed audience of CRAs, sponsors, and clinical operations leaders, Franklyn Health demonstrated the depth of expertise that is fuelling its expansion.

At Franklyn Health, every study is built around three core principles: tight collaboration across the team, meaningful sponsor input throughout the trial, and a culture of moving quickly. This approach to clinical trial management positions Franklyn Health as a trusted partner for sponsors seeking faster, more efficient, and higher-quality clinical research outcomes.

As the clinical research industry continues to evolve, Franklyn Health remains committed to leading conversations that matter — and to delivering clinical trials that move faster, start stronger, and succeed.